Clinical Trial Update: OmegAD (Omega-3 and Alzheimer's Disease) [NA]

View source ↗

Summary

This entry notes that the OmegAD study evaluating omega-3 fatty acids for Alzheimer's disease has completed enrollment/status, with no further results provided …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Alzheimer's Disease | NA | Status: COMPLETED